[1]
Tahir Siddique, Sadaf Farzand, Marryam Khalid, Rizwan Ahmad, Kashif Aziz Ahmad, and Muhammad Maqsood, “Efficacy and Safety of Once-Weekly Semaglutide versus Tirzepatide in Type 2 Diabetes: A 24-Week Randomized Clinical Trial”, JHWCR, vol. 3, no. 1, pp. 1–8, Mar. 2025, doi: 10.61919/qxt0b644.